BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34211845)

  • 1. Radiological Imaging of Gastro-Entero-Pancreatic Neuroendocrine Tumors. The Review of Current Literature Emphasizing the Diagnostic Value of Chosen Imaging Methods.
    Półtorak-Szymczak G; Budlewski T; Furmanek MI; Wierzba W; Sklinda K; Walecki J; Mruk B
    Front Oncol; 2021; 11():670233. PubMed ID: 34211845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoscopic techniques for diagnosis and treatment of gastro-entero-pancreatic neuroendocrine neoplasms: Where we are.
    Rossi RE; Elvevi A; Gallo C; Palermo A; Invernizzi P; Massironi S
    World J Gastroenterol; 2022 Jul; 28(26):3258-3273. PubMed ID: 36051341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent epidemiology of patients with gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN) in Japan: a population-based study.
    Masui T; Ito T; Komoto I; Uemoto S;
    BMC Cancer; 2020 Nov; 20(1):1104. PubMed ID: 33189127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Value of Somatostatin Receptor Scintigraphy (SRS) in Patients with NETG1/G2 Pancreatic Neuroendocrine Neoplasms (p-NENs).
    Kolasińska-Ćwikła AD; Konsek SJ; Buscombe JR; Maciejkiewicz K; Cichocki A; Roszkowska-Purska K; Sawicki Ł; Tenderenda M; Cwikla JB
    Nucl Med Rev Cent East Eur; 2019; 22(1):1-7. PubMed ID: 30276787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone secreting gastro-entero-pancreatic neuroendocrine neoplasias (GEP-NEN): When to consider, how to diagnose?
    Fottner C; Ferrata M; Weber MM
    Rev Endocr Metab Disord; 2017 Dec; 18(4):393-410. PubMed ID: 29256148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor mutation burden in gastro-entero-pancreatic-neuroendocrine neoplasms.
    Jeong SY; Park YS; Lee J; Jang J; Jeon Y; Jung YJ; Choi D; Hong J; Kim ST
    J Gastrointest Oncol; 2023 Aug; 14(4):1707-1714. PubMed ID: 37720428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the Polish Network of Neuroendocrine Tumours).
    Kos-Kudła B; Blicharz-Dorniak J; Strzelczyk J; Bałdys-Waligórska A; Bednarczuk T; Bolanowski M; Boratyn-Nowicka A; Borowska M; Cichocki A; Ćwikła JB; Falconi M; Foltyn W; Handkiewicz-Junak D; Hubalewska-Dydejczyk A; Jarząb B; Junik R; Kajdaniuk D; Kamiński G; Kolasińska-Ćwikła A; Kowalska A; Król R; Królicki L; Krzakowski M; Kunikowska J; Kuśnierz K; Lampe P; Lange D; Lewczuk-Myślicka A; Lewiński A; Lipiński M; Londzin-Olesik M; Marek B; Nasierowska-Guttmejer A; Nawrocki S; Nowakowska-Duława E; Pilch-Kowalczyk J; Rosiek V; Ruchała M; Siemińska L; Sowa-Staszczak A; Starzyńska T; Steinhof-Radwańska K; Sworczak K; Syrenicz A; Szawłowski A; Szczepkowski M; Wachuła E; Zajęcki W; Zemczak A; Zgliczyński W; Zieniewicz K
    Endokrynol Pol; 2017; 68(2):79-110. PubMed ID: 28597909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status of Interventional Radiology in the management of Gastro-Entero-Pancreatic Neuroendocrine Tumours (GEP-NETs).
    Orgera G; Krokidis M; Cappucci M; Gourtsoyianni S; Tipaldi MA; Hatzidakis A; Rebonato A; Rossi M
    Cardiovasc Intervent Radiol; 2015 Feb; 38(1):13-24. PubMed ID: 25366087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How should incidental NEN of the pancreas and gastrointestinal tract be followed?
    Ariotti R; Partelli S; Muffatti F; Andreasi V; Della Sala F; Falconi M
    Rev Endocr Metab Disord; 2018 Jun; 19(2):139-144. PubMed ID: 29527619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digestive Neuroendocrine Tumor Distribution and Characteristics According to the 2010 WHO Classification: a Single Institution Experience in Lebanon.
    Kourie HR; Ghorra C; Rassy M; Kesserouani C; Kattan J
    Asian Pac J Cancer Prev; 2016; 17(5):2679-81. PubMed ID: 27268650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stage IV Gastro-Entero-Pancreatic Neuroendocrine Neoplasms: A Risk Score to Predict Clinical Outcome.
    Panzuto F; Merola E; Pavel ME; Rinke A; Kump P; Partelli S; Rinzivillo M; Rodriguez-Laval V; Pape UF; Lipp R; Gress T; Wiedenmann B; Falconi M; Delle Fave G
    Oncologist; 2017 Apr; 22(4):409-415. PubMed ID: 28232598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resection of the primary tumor improves survival in patients with gastro-entero-pancreatic neuroendocrine neoplasms with liver metastases: A SEER-based analysis.
    Zheng M; Li Y; Li T; Zhang L; Zhou L
    Cancer Med; 2019 Sep; 8(11):5128-5136. PubMed ID: 31328428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastro-entero-pancreatic neuroendocrine tumors: Is now time for a new approach?
    Berardi R; Torniai M; Savini A; Rinaldi S; Cascinu S
    World J Clin Oncol; 2016 Apr; 7(2):131-4. PubMed ID: 27081635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microenvironment and tumor inflammatory features improve prognostic prediction in gastro-entero-pancreatic neuroendocrine neoplasms.
    Milione M; Miceli R; Barretta F; Pellegrinelli A; Spaggiari P; Tagliabue G; Centonze G; Paolino C; Mangogna A; Kankava K; Pusceddu S; Giacomelli L; Corti A; Cotsoglou C; Mazzaferro V; Sozzi G; de Braud F; Pruneri G; Anichini A
    J Pathol Clin Res; 2019 Oct; 5(4):217-226. PubMed ID: 31136102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study.
    Zhang M; Zhao P; Shi X; Zhao A; Zhang L; Zhou L
    BMC Endocr Disord; 2017 Jul; 17(1):39. PubMed ID: 28705205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Assessment of Gastropancreatic Neuroendocrine Neoplasm: Prospects and Limits of Radiomics.
    De Muzio F; Pellegrino F; Fusco R; Tafuto S; Scaglione M; Ottaiano A; Petrillo A; Izzo F; Granata V
    Diagnostics (Basel); 2023 Sep; 13(18):. PubMed ID: 37761243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis, Management and Theragnostic Approach of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms.
    Piscopo L; Zampella E; Pellegrino S; Volpe F; Nappi C; Gaudieri V; Fonti R; Vecchio SD; Cuocolo A; Klain M
    Cancers (Basel); 2023 Jul; 15(13):. PubMed ID: 37444593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complications of surgery for gastro-entero-pancreatic neuroendocrine neoplasias.
    Albers MB; Almquist M; Bergenfelz A; Nordenström E
    Langenbecks Arch Surg; 2020 Mar; 405(2):137-143. PubMed ID: 32291468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Correlation Between [
    Yu J; Li N; Li J; Lu M; Leal JP; Tan H; Su H; Fan Y; Zhang Y; Zhao W; Zhu H; Pomper MG; Zhou Y; Yang Z
    Mol Imaging Biol; 2019 Oct; 21(5):984-990. PubMed ID: 30796708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the Polish Network of Neuroendocrine Tumours).
    Kos-Kudła B; Blicharz-Dorniak J; Handkiewicz-Junak D; Jarząb B; Jarząb M; Kunikowska J; Kuśnierz K; Król R; Królicki L; Krzakowski M; Nasierowska-Guttmejer A; Nowakowska-Duława E; Patkowski W; Szawłowski AW; ;
    Endokrynol Pol; 2013; 64(6):418-43. PubMed ID: 24431116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.